Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ploeger

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Die Rehabilitation|November 1, 1973
[Evaluation of the rehabilitation outcome in a therapeutic community with the help of sociometry and variables of the personality structure (author's transl)]E Steinmeyer, H Reiff, A Ploeger
Toxicology and Applied Pharmacology|February 1, 2000
Physiologically based pharmacokinetic modeling of glycyrrhizic acid, a compound subject to presystemic metabolism and enterohepatic cyclingB A Ploeger, J Meulenbelt, J DeJongh
Clinical Pharmacology and Therapeutics|July 9, 2010
Clinical trial simulation: a reviewN Holford, S C Ma, B A Ploeger
Perception & Psychophysics|August 28, 2001
Differential activation solution to the motion correspondence problemL A Gilroy, H S Hock, A Ploeger
Transplantation|February 12, 1998
HLA antibody screening: comparison of a solid phase enzyme-linked immunoassay with antiglobulin-augmented lymphocytotoxicityS B Moore, N A Ploeger, S R DeGoey
Drug Discovery Today|May 14, 2013
The virtue of translational PKPD modeling in drug discovery: selecting the right clinical candidate while sparing animal livesTjerk Bueters, Bart A Ploeger, Sandra A G Visser
Toxicology and Applied Pharmacology|August 10, 1999
Estimation of systemic toxicity of acrylamide by integration of in vitro toxicity data with kinetic simulationsJ DeJongh, M Nordin-Andersson, B A Ploeger, et al.
Drug Metabolism and Pharmacokinetics|March 3, 2009
Incorporating receptor theory in mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modelingBart A Ploeger, Piet H van der Graaf, Meindert Danhof
Journal of Pharmacokinetics and Pharmacodynamics|January 17, 2008
Extensions to the visual predictive check to facilitate model performance evaluationTeun M Post, Jan I Freijer, Bart A Ploeger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 27, 2014
Translational pharmacokinetic modeling of fingolimod (FTY720) as a paradigm compound subject to sphingosine kinase-mediated phosphorylationNelleke Snelder, Bart A Ploeger, Olivier Luttringer, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Die Rehabilitation|November 1, 1973
[Evaluation of the rehabilitation outcome in a therapeutic community with the help of sociometry and variables of the personality structure (author's transl)]E Steinmeyer, H Reiff, A Ploeger
Toxicology and Applied Pharmacology|February 1, 2000
Physiologically based pharmacokinetic modeling of glycyrrhizic acid, a compound subject to presystemic metabolism and enterohepatic cyclingB A Ploeger, J Meulenbelt, J DeJongh
Clinical Pharmacology and Therapeutics|July 9, 2010
Clinical trial simulation: a reviewN Holford, S C Ma, B A Ploeger
Perception & Psychophysics|August 28, 2001
Differential activation solution to the motion correspondence problemL A Gilroy, H S Hock, A Ploeger
Transplantation|February 12, 1998
HLA antibody screening: comparison of a solid phase enzyme-linked immunoassay with antiglobulin-augmented lymphocytotoxicityS B Moore, N A Ploeger, S R DeGoey
Drug Discovery Today|May 14, 2013
The virtue of translational PKPD modeling in drug discovery: selecting the right clinical candidate while sparing animal livesTjerk Bueters, Bart A Ploeger, Sandra A G Visser
Toxicology and Applied Pharmacology|August 10, 1999
Estimation of systemic toxicity of acrylamide by integration of in vitro toxicity data with kinetic simulationsJ DeJongh, M Nordin-Andersson, B A Ploeger, et al.
Drug Metabolism and Pharmacokinetics|March 3, 2009
Incorporating receptor theory in mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modelingBart A Ploeger, Piet H van der Graaf, Meindert Danhof
Journal of Pharmacokinetics and Pharmacodynamics|January 17, 2008
Extensions to the visual predictive check to facilitate model performance evaluationTeun M Post, Jan I Freijer, Bart A Ploeger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 27, 2014
Translational pharmacokinetic modeling of fingolimod (FTY720) as a paradigm compound subject to sphingosine kinase-mediated phosphorylationNelleke Snelder, Bart A Ploeger, Olivier Luttringer, et al.
Pageof 7